Titan Pharmaceuticals (NSDQ:TTNP) said last week that it inked a $10 million venture loan and security deal with Horizon Technology Finance Corp.
The first $7 million tranche was triggered after the groups inked a deal, Titan reported, and a second option of $3 million is available to the California-based company until March 31, 2018, contingent upon certain revenue and development milestones.
Get the full story at our sister site, Drug Delivery Business News.
The post Titan Pharmaceuticals lands $10m debt facility appeared first on MassDevice.